Cyclooxygenase-2 Inhibitors - Index

Medications listed in the tables and non-FDA approved indications included in these retrospective criteria are not indicative of Texas Vendor Drug Program formulary coverage.

  • Revision history
    • July 21, 2023
    • July 23, 2021
    • July 2019
    • May 2019
    • May 2016
    • Oct. 2014
    • Feb. 2013
    • Dec. 2012
    • March 2011
    • Jan. 2011
    • Oct. 2007
    • Feb. 2006
    • Jan. 2006
    • Jan. 2004
    • Jan. 2003
  • Initially developed
    • Jan. 2002